PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $96,000 | +6.7% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $90,000 | +26.8% | 12,000 | 0.0% | 0.01% | +30.0% |
| Q4 2017 | $71,000 | -19.3% | 12,000 | 0.0% | 0.01% | -23.1% |
| Q3 2017 | $88,000 | +8.6% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $81,000 | -28.3% | 12,000 | 0.0% | 0.01% | -31.6% |
| Q1 2017 | $113,000 | +8.7% | 12,000 | 0.0% | 0.02% | -5.0% |
| Q4 2016 | $104,000 | -18.1% | 12,000 | -40.0% | 0.02% | -13.0% |
| Q3 2016 | $127,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|